Department of Nephrology, Hospital de Pediatría Prof. Dr. Juan P. Garrahan, Combate de los Pozos 1881, CP 1245 Buenos Aires, Argentina.
Pediatr Nephrol. 2012 Apr;27(4):637-42. doi: 10.1007/s00467-011-2027-2. Epub 2011 Oct 29.
Acute peritoneal dialysis (PD) is the preferred therapy for renal replacement in children with post-diarrheal hemolytic uremic syndrome (D+ HUS), but peritonitis remains a frequent complication of this procedure. We reviewed data from 149 patients with D+ HUS who had undergone acute PD with the aim of determining the prevalence and risk factors for the development of peritonitis. A total of 36 patients (24.2%) presented peritonitis. The median onset of peritonitis manifestations was 6 (range 2-18) days after the initiation of dialysis treatment, and Gram-positive microorganisms were the predominant bacterial type isolated (15/36 patients). The patients were divided into two groups: with or without peritonitis, respectively. Univariate analysis revealed that a longer duration of the oligoanuric period, more days of dialysis, catheter replacement, stay in the intensive care unit, and hypoalbuminemia were significantly associated to the development of peritonitis. The multivariate analysis, controlled by duration of PD, identified the following independent risk factors for peritonitis: catheter replacement [p = 0.037, odds ratio (OR) 1.33, 95% confidence interval (CI) 1.02-1.73], stay in intensive care unit (p = 0.0001, OR 2.62, 95% CI 1.65-4.19), and hypoalbuminemia (p = 0.0076, OR 1.45, 95% CI 1.10-1.91). Based on these findings, we conclude that the optimization of the aseptic technique during catheter manipulation and early nutritional support are targets for the prevention of peritonitis, especially in critically ill patients.
急性腹膜透析(PD)是治疗腹泻后溶血尿毒综合征(D+HUS)患儿肾替代治疗的首选方法,但腹膜炎仍然是该操作的常见并发症。我们回顾了 149 例接受急性 PD 的 D+HUS 患儿的数据,旨在确定腹膜炎的发生率和危险因素。共有 36 例(24.2%)患儿出现腹膜炎。腹膜炎表现的中位发病时间为透析治疗开始后 6 天(范围 2-18 天),分离出的主要细菌类型为革兰阳性微生物(15/36 例)。患者分为两组:有或没有腹膜炎。单因素分析显示,少尿期时间较长、透析天数较多、导管更换、入住重症监护病房和低白蛋白血症与腹膜炎的发生显著相关。经 PD 时间校正的多因素分析确定了腹膜炎的独立危险因素:导管更换(p=0.037,优势比 [OR] 1.33,95%置信区间 [CI] 1.02-1.73)、入住重症监护病房(p=0.0001,OR 2.62,95% CI 1.65-4.19)和低白蛋白血症(p=0.0076,OR 1.45,95% CI 1.10-1.91)。基于这些发现,我们得出结论,优化导管操作期间的无菌技术和早期营养支持是预防腹膜炎的目标,特别是对重症患儿。